ArticleOncotarget2017

Activated spleen tyrosine kinase promotes malignant progression of oral squamous cell carcinoma via mTOR/S6 signaling pathway in an ERK1/2-independent manner.

Pan Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.